Impact fact

Adi has helped shape access and pricing strategy across multiple therapy areas and geographies with 20-plus pharma and biotech companies.


Adi is a principal within ZS’s value and access practice area. He leads global market access and pricing projects with several large and small biopharmaceutical clients. 




Adi’s deep experience and thought leadership in the global market access and pricing space has been shaped over the past 14 years through strategic engagement with clients around the world, including North America, EU5, Japan, Latin America, Eastern Europe and Africa. His passion is in the intersection of science and business, helping clients define market access and pricing strategies for pipeline and inline assets. Adi’s experience spans a variety of therapy areas, including oncology, vaccines, immunology and infectious diseases.



Prior experience

Before joining ZS in 2008, Adi worked as a strategy consultant with Oliver Wyman, where he focused on strategy and operations projects across various industries.




Adi holds an MBA from Duke University, with concentration in strategy and finance. He also holds a B.S. in chemical engineering and an M.S. in petroleum engineering.